Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La
- 1 April 2025
- journal article
- Published by SAGE Publications in Lupus
- Vol. 34 (6) , 571-578
Abstract
Objectives: The aim of the present study was to describe demographic, clinical, and immunological characteristics of SLE patients with anti-La/SSB antibodies positive versus anti-La/SSB negative patients. Methods: Retrospective cross-sectional study, including all patients with SLE (≥4 ACR-1997 criteria) recruited in RELESSER registry. Sociodemographic, clinical, serological and comorbidities variables were collected. Anti-Ro-/La + patients were compared with the rest of the patients. Results: In a study involving 4219 systemic lupus erythematosus (SLE) patients, 44/3893 (1.1%) were found to be positive for isolated anti-La/SSB antibodies. The mean age was 33.77 years, with a majority being female (88.6%) and Caucasian (90.5%). The most frequent comorbidities were smoking (48.8%), dyslipidemia (47.7%), and arterial hypertension (31.8%). Photosensitivity and mucosal ulcers were more common in anti-Ro+/La + patients compared to anti-Ro+/La- and anti-Ro-/La- patients. Anti-Ro+/La + patients had a lower frequency of lupus nephritis compared to anti-Ro+/La- patients. A multivariable regression model, considering various confounding factors, was applied to compare anti-La/SSB positive patients with negative ones. Isolated anti-La/SSB positive patients showed a lower occurrence of lupus nephritis and a higher frequency of cardiac manifestations. Conclusions: The study suggests that patients with isolated anti-La/SSB antibodies may have a unique clinical profile, with a potential protective effect against lupus nephritis but an increased likelihood of cardiac manifestations.Keywords
This publication has 21 references indexed in Scilit:
- Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosusAutoimmunity Reviews, 2017
- Registro nacional de pacientes con lupus eritematoso sistémico de la Sociedad Española de Reumatología: objetivos y metodologíaReumatología Clínica, 2014
- The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndromeAutoimmunity Reviews, 2011
- Anti-Ro antibody and cutaneous vasculitis in systemic lupus erythematosusClinical Rheumatology, 2008
- Cardiac Rhythm and Conduction Disturbances: What is the Role of Autoimmune Mechanisms?Herz, 2000
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with Systemic Lupus ErythematosusArthritis & Rheumatism, 1997
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- ANTI La(SSB) IDENTIFIES A DISTINCTIVE SUBGROUP OF SYSTEMIC LUPUS ERYTHEMATOSUSRheumatology, 1988
- Correlation of a Precipitin Reaction to an RNA-Protein Antigen and a Low Prevalence of Nephritis in Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1972